Electromyostimulation (EMS) of Astronauts in Spaceflight (Easymotion-2)
Easymotion-2
ElectroMyoStimulation (EMS Body Suit) Protocol to Improve Exercise Outcome in Space Missions (EasyMotion-2)
1 other identifier
interventional
12
1 country
1
Brief Summary
This is a prospective spaceflight study involving an investigational non-risk device called the EasyMotionSkin for whole body electric muscle (myo) stimulation (WB-EMS) onboard the International Space Station (ISS). The purpose of this study is to show:
- optimized exercise outcome with EMS in human spaceflight
- demonstrate efficacy of EMS as alternative inflight exercise protocol
- provide a time-saving and reliable EMS-assisted exercise protocol compliant to astronauts for later use in planetary habitats and future deep space exploration Eight (n=8) astronauts on long duration missions will take part in this study. This experiment uses the following hardware/software (HW \& SW): (A) EasymotionSkin suit (dry electrode muscle stimulation), B) non-invasive hand-held Myoton device (digitized passive muscle stiffness data collection). C) a customized Myoton body template suit (elastic yoga suit with customized anatomical reference labels to aid inflight Myoton data collection on dedicated perforated 2x2 cm small skin fields) at 5 different skin measurement points (MP), neck, back, shoulder, legs. Before and after flight the following tests will be done once: Myoton data collection, dynamometry strength test, magnetic resonance imaging (MRI) for baseline comparison. Researchers will compare data from a non EMS control group (non EMS Astronauts, retrospective) to see if changes of passive muscle stiffness is seen in EMS Astronauts before, during and after spaceflight
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2024
CompletedFirst Posted
Study publicly available on registry
July 9, 2024
CompletedStudy Start
First participant enrolled
September 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2029
March 23, 2026
March 1, 2026
3.9 years
May 23, 2024
March 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (37)
Myoton Tone (baseline preflight)
Passive muscle tone \[Hz\] numerical indices. Abbreviations for Outcome Measures 1-37: Hertz, Hz; Newton/meter, N/m; before launch (preflight), L-; recovery (postflight), R+; inflight days, FD; not earlier than, NET; not later than, NLT; electro-myo-stimulation, EMS; versus/against, vs; surface electromyography, sEMG.
L-105+/-30 days (time window)
Myoton Tone (recovery postflight)
Passive muscle tone \[Hz\] numerical indices. Abbreviations for Outcome Measures 1-37: Hertz, Hz; Newton/meter, N/m; before launch (preflight), L-; recovery (postflight), R+; inflight days, FD; not earlier than, NET; not later than, NLT; electromyostimulation, EMS; versus/against, vs; surface electromyography, sEMG.
R+30+/-10 days (time window)
Myoton Tone (inflight, preEMS-1)
Passive muscle tone \[Hz\] numerical indices. Abbreviations: see Outcome1
FD20-30 days (time window)
Myoton Tone (inflight, preEMS-2)
Passive muscle tone \[Hz\] numerical indices. Abbreviations: see Outcome1
FD60-80 days (time window)
Myoton Tone (inflight, post EMS-1)
Passive muscle tone \[Hz\] numerical indices. Abbreviations: see Outcome1
NET R-18 days (time window)
Myoton Tone (inflight, post EMS-2)
Passive muscle tone \[Hz\] numerical indices. Abbreviations: see Outcome1
NLT R-12 days (time window)
Myoton stiffness (baseline, preflight).
Passive muscle stiffness \[N/m\] numerical indices. Abbreviations: see Outcome 1
L-105+/-30 days (time window)
Myoton stiffness (recovery, postflight).
Passive muscle stiffness \[N/m\] numerical indices. Abbreviations: see Outcome 1
R+30+/-10 days (time window)
Myoton stiffness (inflight, preEMS-1)
Passive muscle stiffness \[N/m\] numerical indices. Abbreviations: see Outcome 1
FD20-30 days (time window)
Myoton stiffness (inflight, preEMS-2)
Passive muscle stiffness \[N/m\] numerical indices. Abbreviations: see Outcome 1
FD60-80 days (time window)
Myoton stiffness (inflight, postEMS-1)
Passive muscle stiffness \[N/m\] numerical indices. Abbreviations: see Outcome 1
NET R-18 days (time window)
Myoton stiffness (inflight, postEMS-2)
Passive muscle stiffness \[N/m\] numerical indices. Abbreviations: see Outcome 1
NLT R-12 days (time window)
EMS body stimulation (inflight EMS1)
1st out of a total of 12 (1/12) single EMS-assisted inflight exercise between NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out") at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24. Abbreviations: see Outcome 1.
NET R-60 and NLT R-21 days (time window)
EMS body stimulation (inflight EMS2)
2/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out") at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.
NET R-60 and NLT R-21 days (time window)
EMS body stimulation (inflight EMS3)
3/12 single EMS-assisted inflight exercise, NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out")at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.
NET R-60 and NLT R-21 days(time window)
EMS body stimulation (inflight EMS4)
4/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out")at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.
NET R-60 and NLT R-21 days (time window)
EMS body stimulation (inflight EMS5)
5/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out")at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.
NET R-60 and NLT R-21 days (time window)
EMS body stimulation (inflight EMS6)
6/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out")at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.
NET R-60 and NLT R-21 days (time window)
EMS body stimulation (inflight EMS7)
7/12 single EMS-assisted inflight exercise, NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out")at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.
NET R-60 and NLT R-21 days (time window)
EMS body stimulation (inflight EMS8)
8/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out") at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.
NET R-60 and NLT R-21 days (time window)
EMS body stimulation (inflight EMS9)
9/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out") at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.
NET R-60 and NLT R-21 days (time window)
EMS body stimulation (inflight EMS10)
10/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out") at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.
NET R-60 and NLT R-21 days (time window)
EMS body stimulation (inflight EMS11)
11/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out") at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.
NET R-60 and NLT R-21 days (time window)
EMS body stimulation (inflight EMS12)
Last out of a total of twelve (12/12) single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out") at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.
NET R-60 and NLT R-21 days (time window)
Dynamometry (baseline, preflight/power).
Standard muscle isometric/isokinetic tests (power \[Watt\] on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus). Abbreviations: see Outcome 1
L-105+/-30 days (time window)
Dynamometry (baseline, preflight/torque).
Standard muscle isometric/isokinetic tests ( torque \[Nm\]) on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus). Abbreviations: see Outcome 1
L-105+/-30 days (time window)
sEMG (baseline, preflight/amplitude).
Non-invasive sEMG by amplitude on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus) as part of dynamometry. Abbreviations: see Outcome 1
L-105+/-30 days (time window)
sEMG (baseline, preflight/frequency).
Non-invasive sEMG by frequency (Hz) on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus) as part of dynamometry. Abbreviations: see Outcome 1
L-105+/-30 days (time window)
Dynamometry (recovery postflight/power).
Standard muscle isometric/isokinetic tests (power \[Watt\] on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus). Abbreviations: see Outcome 1
R+30+/-10 days (time window)
Dynamometry (recovery postflight/torque).
Standard muscle isometric/isokinetic tests (torque \[Nm\] on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus). Abbreviations: see Outcome 1
R+30+/-10 days (time window)
sEMG (recovery postflight/amplitude).
Non-invasive surface EMG (amplitude) on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus) as part of dynamometry. Abbreviations: see Outcome 1
R+30+/-10 days (time window)
sEMG (recovery postflight/frequency).
Non-invasive surface EMG (Hz) on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus) as part of dynamometry. Abbreviations: see Outcome 1
R+30+/-10 days (time window)
Magnetic Resonance Imaging (MRI) (baseline preflight).
Standard clinical structural analysis by optical sections of lower leg and lumbar back muscle profile/volume area (square/3-D, centimeters). Abbreviations: see Outcome 1
L-105+/-30 days (time window)
Magnetic Resonance Imaging (MRI) (recovery postflight).
Standard clinical structural analysis by optical sections of lower leg and lumbar back muscle profile/volume area (square/3-D, centimeters). Abbreviations: see Outcome 1
R+30+/-10 days (time window)
EMS protocol report (ms)
Multiple measurements (milliseconds=ms) will be aggregated for each of the 12 single inflight EMS session (see Outcome 13-24) to report on inflight EMS protocol and to collect technical data (of muscle stimulation) for whole body inflight EMS monitoring and assessment. see Outcome1
NET R-60 and NLT R-21 days (time window)
EMS protocol report (minutes)
Multiple measurements (duration/min.) will be aggregated for each of the 12 single inflight EMS session (see Outcome 13-24) to report on inflight EMS protocol and to collect technical data (of muscle stimulation) for whole body inflight EMS monitoring and assessment. Abbreviations: see Outcome1
NET R-60 and NLT R-21 days (time window)
EMS protocol report (Hz)
Multiple measurements (frequency/Hz) will be aggregated for each of the 12 single inflight EMS session (see Outcome 13-24) to report on inflight EMS protocol and to collect technical data (of muscle stimulation) for whole body inflight EMS monitoring and assessment. Abbreviations: see Outcome1
NET R-60 and NLT R-21 days (time window)
Study Arms (1)
EMS (electromyostimulation) participants
EXPERIMENTALHealthy Astronauts that perform EMS-assisted inflight exercise onboard the International Space Station
Interventions
EasymotionSkin body suit for digitally controlled electric impulses via Easymotion-2 software on crew iPad (frequency, impulse rate, duration) are transferred from integrated dry electrodes of the EMS- stimulation suit to activate surface muscle groups of the body (trunk), arms and legs
The non-invasive Myoton technology collects data from passive muscle properties (tone and stiffness) obtained from selected anatomical surface muscle groups
As a standard method, surface EMG collects data from nerve impulse-triggered active muscle contractions, pre/postflight only
MRI is a clinically standard (non-radiation) imaging method to study structural changes of the human body (organs, muscle, bones, tendons) at the macroscopic level, pre/postflight only
Dynamometry is a standard functional and diagnostic method to test muscle strength in sports and rehabilitation. pre/postflight only
Eligibility Criteria
You may qualify if:
- Astronauts with active Flight Medical
You may not qualify if:
- Heart disease
- Liver disease
- Diabetes
- Thrombosis
- Extreme blood pressure
- Abdominal \& inguinal hernias (bulges)
- Strong neurological diseases
- Pregnancy
- Cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Charité - Universitätsmedizin Berlin
Mitte, State of Berlin, 10117, Germany
Related Publications (3)
Schoenrock B, Muckelt PE, Hastermann M, Albracht K, MacGregor R, Martin D, Gunga HC, Salanova M, Stokes MJ, Warner MB, Blottner D. Muscle stiffness indicating mission crew health in space. Sci Rep. 2024 Feb 20;14(1):4196. doi: 10.1038/s41598-024-54759-6.
PMID: 38378866BACKGROUNDMuckelt PE, Warner MB, Cheliotis-James T, Muckelt R, Hastermann M, Schoenrock B, Martin D, MacGregor R, Blottner D, Stokes M. Protocol and reference values for minimal detectable change of MyotonPRO and ultrasound imaging measurements of muscle and subcutaneous tissue. Sci Rep. 2022 Aug 11;12(1):13654. doi: 10.1038/s41598-022-17507-2.
PMID: 35953503BACKGROUNDSchoenrock B, Zander V, Dern S, Limper U, Mulder E, Veraksits A, Viir R, Kramer A, Stokes MJ, Salanova M, Peipsi A, Blottner D. Bed Rest, Exercise Countermeasure and Reconditioning Effects on the Human Resting Muscle Tone System. Front Physiol. 2018 Jul 3;9:810. doi: 10.3389/fphys.2018.00810. eCollection 2018.
PMID: 30018567BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dieter Blottner, PhD
Charite-Universitätsmedizin Berlin, Germany
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Subject A to K
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Dr. (PhD)
Study Record Dates
First Submitted
May 23, 2024
First Posted
July 9, 2024
Study Start
September 15, 2025
Primary Completion (Estimated)
July 31, 2029
Study Completion (Estimated)
December 31, 2029
Last Updated
March 23, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Results will not be shared to other researchers due to privacy reasons of participating Astronauts related to their Space Agencies